Beneficial Effects of Time-Restricted Eating on Metabolic Diseases: A Systemic Review and Meta-Analysis.
Shinje MoonJiseung KangSang Hyun KimHye Soo ChungYoon Jung KimJae Myung YuSung Tae ChoChang-Myung OhTae KimPublished in: Nutrients (2020)
Various behavioral and physiological pathways follow a pre-determined, 24 hour cycle known as the circadian rhythm. Metabolic homeostasis is regulated by the circadian rhythm. Time-restricted eating (TRE) is a type of intermittent fasting based on the circadian rhythm. In this study, we aim to analyze systemically the effects of TRE on body weight, body composition, and other metabolic parameters. We reviewed articles from PubMed, EMBASE, and the Cochrane Library to identify clinical trials that compared TRE to a regular diet. We included 19 studies for meta-analysis. Participants following TRE showed significantly reduced body weight (mean difference (MD), -0.90; 95% confidence interval (CI): -1.71 to -0.10) and fat mass (MD: -1.58, 95% CI: -2.64 to -0.51), while preserving fat-free mass (MD, -0.24; 95% CI: -1.15 to 0.67). TRE also showed beneficial effects on cardiometabolic parameters such as blood pressure (systolic BP, MD, -3.07; 95% CI: -5.76 to -0.37), fasting glucose concentration (MD, -2.96; 95% CI, -5.60 to -0.33), and cholesterol profiles (triglycerides, MD: -11.60, 95% CI: -23.30 to -0.27). In conclusion, TRE is a promising therapeutic strategy for controlling weight and improving metabolic dysfunctions in those who are overweight or obese. Further large-scale clinical trials are needed to confirm these findings and the usefulness of TRE.
Keyphrases
- body weight
- weight loss
- blood pressure
- body composition
- molecular dynamics
- clinical trial
- physical activity
- heart rate
- adipose tissue
- systematic review
- blood glucose
- atrial fibrillation
- bariatric surgery
- insulin resistance
- heart failure
- resistance training
- left ventricular
- case control
- randomized controlled trial
- metabolic syndrome
- fatty acid
- hypertensive patients
- body mass index
- weight gain
- obese patients
- high intensity
- meta analyses
- phase iii
- study protocol
- double blind
- postmenopausal women